Topical silver for infected wounds

Journal of Athletic Training

Volumn 44, Issue 5, 2009, Pages 531-533

  Beam, Joel W ^a  

^a UNIVERSITY OF NORTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTIINFECTIVE AGENT; SILVER DERIVATIVE;

CHRONIC WOUND; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONTAMINATION; DRUG EFFICACY; ECZEMA; ERYTHEMA; HUMAN; HYDROCOLLOID; LEG ULCER; NOTE; PAIN; TREATMENT OUTCOME; ULCER; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

EID: 70349159159     PISSN: 10626050     EISSN: None     Source Type: Journal    
DOI: 10.4085/1062-6050-44.5.531     Document Type: Note

References (6)

1. National Nosocomial Infections Surveillance System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470-485.
2. White R, Cutting K. Exploring the effects of silver in wound management - what is optimal? WOUNDS. 2006;18(11):307-314.
3. Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT. Topical silver for treating infected wounds. Cochrane Database Syst Rev. 2007(1);CD005486. (Pubitemid 351805934)
4. Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2006(1);CD005082.
5. Myers BA. Wound Management: Principles and Practice. 2nd ed. Upper Saddle River, NJ: Pearson Prentice Hall; 2008:94-122.
6. Ameen H, Moore K, Lawrence JC, Harding KG. Investigating the bacterial barrier properties of four contemporary wound dressings. J Wound Care. 2000;9(8):385-388.